Increasing Demand For Personalized Medicine Fueling The Growth Of The Market Due To Advancements In Genomics And Tailored Treatments: Strategic Insights Driving Artificial Intelligence (AI) Pathology Quality Control Market Momentum in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Artificial Intelligence (AI) Pathology Quality Control Market Size By 2025?
The market size of quality control in pathology through artificial intelligence (AI) has witnessed a significant surge in growth over the recent past. The market, valued at $1.46 billion in 2024, is anticipated to increase to $1.78 billion in 2025, recording a compound annual growth rate (CAGR) of 21.6%. This ascending trend during the historical timeframe is credited to factors such as the growing number of cancer cases and chronic diseases, escalating need for accuracy in diagnosis, dearth of proficient pathologists, an increase in expenditure on healthcare, and the rise of personalized medicine.

How Big Is the Artificial Intelligence (AI) Pathology Quality Control Market Size Expected to Grow by 2029?
In the forthcoming years, the market size of the artificial intelligence (AI) pathology quality control area is predicted to witness impressive expansion. The market is forecasted to reach $3.84 billion in 2029, growing annually at a compound rate of 21.2%. The amplification during the prediction period can be associated with an increasing need for automated quality assurance, burgeoning investments in healthcare AI start-ups, the acceptance of cloud-based pathology solutions, the broadening of precision medicine initiatives, and an escalated focus on the early detection of disease. The forecast period sees trends such as advancements in deep learning algorithms, innovations in quality control automation tools, the integration of AI into digital pathology platforms, the emergence of cloud-based pathology solutions and developments in multimodal diagnostic analytics.

View the full report here:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-pathology-quality-control-global-market-report

Which Key Market Drivers Powering Artificial Intelligence (AI) Pathology Quality Control Market Expansion and Growth?
The growth of the artificial intelligence (AI) pathology quality control market is expected to be fueled by the rising demand for personalized medicine. Personalized medicine is a medical approach customizing prevention and treatment measures based on an individual's unique genetic code, lifestyle, and environment. The increasing acceptance of this method is mainly due to advancements in genomics, which support accurate identification of genetic variations and individualized treatments. Artificial intelligence (AI) pathology quality control advances personalized medicine by offering precise and consistent diagnostic insights, which helps in customizing treatment strategies. It minimizes the possibility of diagnostic mistakes by automating quality control procedures, thus enhancing accuracy and reliability and ultimately enhancing personal care for patients. For example, the Personalized Medicine Coalition (PMC), a nonprofit organization based in the United States, reported in February 2024 that the US Food and Drug Administration (FDA) had approved 26 new personalized medicines in 2023, marking a significant rise from the 12 approvals in 2022. Consequently, the growing demand for personalized medicine is anticipated to propel the artificial intelligence (AI) pathology quality control market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28124&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Artificial Intelligence (AI) Pathology Quality Control Market?
Leading players in the artificial intelligence (AI) pathology quality control market are prioritizing the development of innovative solutions, including advanced AI- enabled tools to magnify diagnostic accuracy, streamline lab procedures, and boost the trustworthiness of pathology data. Advanced AI- driven tools imply cutting-edge technologies utilizing AI to execute challenging tasks with superior precision, speed, and productivity. For example, PathAI, an American biotech firm, in November 2023, introduced Artifact Detect 1 to its AISight digital pathology platform. This tool automates the identification and calculation of artifacts in whole slide images (WSI), non-pertinent morphological features that can undermine diagnostic precision. ArtifactDetect reduces misdiagnosis and re-scanning by auto-screening slides for quality issues, thus increasing accuracy, lab efficiency, and total output. This breakthrough promotes timely adjustments like re-staining or re-scanning, eventually enhancing digital workflow and optimizing resources for technicians and pathologists.

What Are the Emerging Segments in the Artificial Intelligence (AI) Pathology Quality Control Market?
The artificial intelligence (AI) pathology quality control market covered in this report is segmented as

1) By Component: Software, Hardware, Services
2) By Deployment Mode: On-Premises, Cloud-Based
3) By Application: Cancer Diagnostics, Infectious Disease Diagnostics, Digital Pathology, Research, Other Applications
4) By End-User: Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:
1) By Software: Image Analysis Software, Diagnostic Decision Support Software, Workflow Management Software, Reporting And Visualization Software
2) By Hardware: Digital Pathology Scanners, Imaging Devices, Servers And Storage Systems, Laboratory Equipment
3) By Services: Implementation Services, Training And Support Services, Maintenance And Upgrade Services, Consulting Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28124&type=smp

Who Are the Global Leaders in the Artificial Intelligence (AI) Pathology Quality Control Market?
Major companies operating in the artificial intelligence (AI) pathology quality control market are Roche Diagnostics GmbH, Danaher Corporation, Philips Healthcare, Agilent Technologies Inc., Hologic Inc., Clinisys Group Ltd., Sectra AB, PathAI Inc., OptraSCAN Inc., Paige.AI Inc., Proscia Inc., Quibim S.L., 3DHISTECH Ltd., Visiopharm A/S, Indica Labs Inc., Ibex Medical Analytics Ltd., Aiosyn B.V., DeepBio Inc., Nucleai Ltd., and Gestalt Diagnostics LLC.

Which are the Top Profitable Regional Markets for the Artificial Intelligence (AI) Pathology Quality Control Industry?
North America was the largest region in the artificial intelligence (AI) pathology quality control market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI) pathology quality control report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28124

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.